Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | MGAT2 | Q10469 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.37 |
| ▸ | CASP1 | P29466 | 2/20 | 0.36 |
| ▸ | FPR1 | P21462 | 4/20 | 0.35 |
| ▸ | FPR2 | P25090 | 4/20 | 0.35 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4638371 | 0.86 | CTSK (0.39) | PARP1CA1CA2ACHECASP1 | |
| SCHEMBL4921278 | 0.80 | TMEM97 (0.39) | PARP1CA1CA2ACHECASP3 | |
| SCHEMBL5277552 | 0.79 | CA1 (0.39) | CA1CA2ACHECASP3FKBP1A | |
| SCHEMBL5242559 | 0.73 | — | — | |
| SCHEMBL4638357 | 0.72 | CTSL (0.43) | CA1ACHECASP1CTSK | |
| SCHEMBL149797 | 0.70 | CASP3 (0.43) | CA1CA2ACHECASP3CASP1 | |
| SCHEMBL4706101 | 0.68 | ALDH1A1 (0.45) | CASP3CASP1CTSK | |
| SCHEMBL8302634 | 0.68 | SRD5A1 (0.43) | FPR1FPR2 | |
| SCHEMBL4858641 | 0.68 | SRD5A1 (0.43) | FPR1FPR2 | |
| SCHEMBL5241778 | 0.68 | TDP1 (0.35) | FPR1FPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1951712-A2 | CHEMICAL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007059952-A2 | 1-BENZAZEPINE-3-SULFONYLAMINO-2-PYRRLORIDONES AS FACTOR XA INHIBITORS | GLAXO GROUP LIMITED (GB) | 2007-05-31 | — | — | WO | disclosed |